Quintiles IMS Holdings, Inc. (Q)

NYSE - NYSE Real Time Price. Currency in USD
71.85-0.25 (-0.35%)
As of 10:45 AM EDT. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close72.10
Bid71.95 x 100
Ask71.98 x 300
Day's Range71.31 - 72.27
52wk Range55.01 - 81.45
1y Target EstN/A
Market Cap17.67B
P/E Ratio (ttm)21.60
Avg Vol (3m)1,144,996
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Business Wireyesterday

    QuintilesIMS Institute Report Identifies Nine Evidence-based Approaches to Transform Drug Development and Commercialization

    Life sciences companies increasingly are seeking new models to connect expanding sets of disparate, non-identified patient-level data streams to better develop and commercialize next-generation medicines. The need for practical, evidence-based approaches is especially acute at a time when scientific advances, the growing need for new medicines, and constrained budgets for healthcare and other social ...

  • Business Wire9 days ago

    QuintilesIMS to Announce Third-Quarter 2016 Results On November 2, 2016

    Quintiles IMS Holdings, Inc. will issue its third-quarter 2016 financial results before the market opens on Wednesday, November 2, 2016. The earnings release and accompanying financial information will be posted on the QuintilesIMS Investor Relations website at http://ir.quintilesims.com.

  • Business Wire10 days ago

    QuintilesIMS Wins Society for Clinical Research Sites’ 2016 Eagle Award

    QuintilesIMS announced today that it has been awarded the 2016 Eagle Award from the Society for Clinical Research Sites for the fourth consecutive year. Presented during the annual SCRS Site Solutions Summit, the site-nominated award recognizes contract research organizations and biopharmaceutical sponsors dedicated to building positive relationships with research sites through leadership, professionalism ...